Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Randomized, Controlled, Parallel Group Study Evaluating Efficacy and Safety of Digital Therapeutic (TH-001) for the Treatment of Prediabetes in Adults

NCT05668819 is registered in ClinicalTrials.gov with Tesu Saglik Teknolojileri A.S. as lead sponsor.

NCT NCT05668819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05668819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Randomized, Controlled, Parallel Group Study Evaluating Efficacy and Safety of Digital Therapeutic (TH-001) for the Treatment of Prediabetes in Adults
Lead sponsor
Tesu Saglik Teknolojileri A.S.
Phase
Not applicable
Overall status
Completed
Start date
February 7, 2023
Completion date
December 24, 2024
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prediabetes